Cargando…

Pregnancy in HIV Clinical Trials in Sub Saharan Africa: Failure of Consent or Contraception?

OBJECTIVE: Higher than expected pregnancy rates have been observed in HIV related clinical trials in Sub-Saharan Africa. We designed a qualitative study to explore the factors contributing to high pregnancy rates among participants in two HIV clinical trials in Sub-Saharan Africa. METHODS: Female an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ssali, Agnes, Namukwaya, Stella, Bufumbo, Leonard, Seeley, Janet, G. Lalloo, David, Kamali, Anatoli, Parkes-Ratanshi, Rosalind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769278/
https://www.ncbi.nlm.nih.gov/pubmed/24039981
http://dx.doi.org/10.1371/journal.pone.0073556
_version_ 1782283958111698944
author Ssali, Agnes
Namukwaya, Stella
Bufumbo, Leonard
Seeley, Janet
G. Lalloo, David
Kamali, Anatoli
Parkes-Ratanshi, Rosalind
author_facet Ssali, Agnes
Namukwaya, Stella
Bufumbo, Leonard
Seeley, Janet
G. Lalloo, David
Kamali, Anatoli
Parkes-Ratanshi, Rosalind
author_sort Ssali, Agnes
collection PubMed
description OBJECTIVE: Higher than expected pregnancy rates have been observed in HIV related clinical trials in Sub-Saharan Africa. We designed a qualitative study to explore the factors contributing to high pregnancy rates among participants in two HIV clinical trials in Sub-Saharan Africa. METHODS: Female and male participants enrolled in one of two clinical HIV trials in south-west Uganda were approached. The trials were a phase III microbicide efficacy trial among HIV negative women using vaginal gel (MDP); and a trial of primary prevention prophylaxis for invasive cryptococcal disease using fluconazole among HIV infected men and women in Uganda (CRYPTOPRO). 14 focus group discussions and 8 in-depth interviews were conducted with HIV positive and negative women and their male partners over a six month period. Areas explored were their experiences about why and when one should get pregnant, factors affecting use of contraceptives, HIV status disclosure and trial product use. RESULTS: All respondents acknowledged being advised of the importance of avoiding pregnancy during the trial. Factors reported to contribute to pregnancy included; trust that the investigational product (oral capsules/vaginal gel) would not harm the baby, need for children, side effects that led to inconsistent contraceptive use, low acceptance of condom use among male partners. Attitudes towards getting pregnant are fluid within couples over time and the trials often last for more than a year. Researchers need to account for high pregnancy rates in their sample size calculations, and consider lesser used female initiated contraceptive options e.g. diaphragm or female condoms. In long clinical trials where there is a high fetal or maternal risk due to investigational product, researchers and ethics committees should consider a review of participants contraceptive needs/pregnancy desire review after a fixed period, as need for children, partners and health status of participants may alter over time.
format Online
Article
Text
id pubmed-3769278
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37692782013-09-13 Pregnancy in HIV Clinical Trials in Sub Saharan Africa: Failure of Consent or Contraception? Ssali, Agnes Namukwaya, Stella Bufumbo, Leonard Seeley, Janet G. Lalloo, David Kamali, Anatoli Parkes-Ratanshi, Rosalind PLoS One Research Article OBJECTIVE: Higher than expected pregnancy rates have been observed in HIV related clinical trials in Sub-Saharan Africa. We designed a qualitative study to explore the factors contributing to high pregnancy rates among participants in two HIV clinical trials in Sub-Saharan Africa. METHODS: Female and male participants enrolled in one of two clinical HIV trials in south-west Uganda were approached. The trials were a phase III microbicide efficacy trial among HIV negative women using vaginal gel (MDP); and a trial of primary prevention prophylaxis for invasive cryptococcal disease using fluconazole among HIV infected men and women in Uganda (CRYPTOPRO). 14 focus group discussions and 8 in-depth interviews were conducted with HIV positive and negative women and their male partners over a six month period. Areas explored were their experiences about why and when one should get pregnant, factors affecting use of contraceptives, HIV status disclosure and trial product use. RESULTS: All respondents acknowledged being advised of the importance of avoiding pregnancy during the trial. Factors reported to contribute to pregnancy included; trust that the investigational product (oral capsules/vaginal gel) would not harm the baby, need for children, side effects that led to inconsistent contraceptive use, low acceptance of condom use among male partners. Attitudes towards getting pregnant are fluid within couples over time and the trials often last for more than a year. Researchers need to account for high pregnancy rates in their sample size calculations, and consider lesser used female initiated contraceptive options e.g. diaphragm or female condoms. In long clinical trials where there is a high fetal or maternal risk due to investigational product, researchers and ethics committees should consider a review of participants contraceptive needs/pregnancy desire review after a fixed period, as need for children, partners and health status of participants may alter over time. Public Library of Science 2013-09-10 /pmc/articles/PMC3769278/ /pubmed/24039981 http://dx.doi.org/10.1371/journal.pone.0073556 Text en © 2013 Ssali et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Ssali, Agnes
Namukwaya, Stella
Bufumbo, Leonard
Seeley, Janet
G. Lalloo, David
Kamali, Anatoli
Parkes-Ratanshi, Rosalind
Pregnancy in HIV Clinical Trials in Sub Saharan Africa: Failure of Consent or Contraception?
title Pregnancy in HIV Clinical Trials in Sub Saharan Africa: Failure of Consent or Contraception?
title_full Pregnancy in HIV Clinical Trials in Sub Saharan Africa: Failure of Consent or Contraception?
title_fullStr Pregnancy in HIV Clinical Trials in Sub Saharan Africa: Failure of Consent or Contraception?
title_full_unstemmed Pregnancy in HIV Clinical Trials in Sub Saharan Africa: Failure of Consent or Contraception?
title_short Pregnancy in HIV Clinical Trials in Sub Saharan Africa: Failure of Consent or Contraception?
title_sort pregnancy in hiv clinical trials in sub saharan africa: failure of consent or contraception?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769278/
https://www.ncbi.nlm.nih.gov/pubmed/24039981
http://dx.doi.org/10.1371/journal.pone.0073556
work_keys_str_mv AT ssaliagnes pregnancyinhivclinicaltrialsinsubsaharanafricafailureofconsentorcontraception
AT namukwayastella pregnancyinhivclinicaltrialsinsubsaharanafricafailureofconsentorcontraception
AT bufumboleonard pregnancyinhivclinicaltrialsinsubsaharanafricafailureofconsentorcontraception
AT seeleyjanet pregnancyinhivclinicaltrialsinsubsaharanafricafailureofconsentorcontraception
AT glalloodavid pregnancyinhivclinicaltrialsinsubsaharanafricafailureofconsentorcontraception
AT kamalianatoli pregnancyinhivclinicaltrialsinsubsaharanafricafailureofconsentorcontraception
AT parkesratanshirosalind pregnancyinhivclinicaltrialsinsubsaharanafricafailureofconsentorcontraception